Related references
Note: Only part of the references are listed.A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression
Chen Zhang et al.
PSYCHOPHARMACOLOGY (2014)
Ion channels in genetic and acquired forms of epilepsy
Holger Lerche et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
C. S. Weickert et al.
MOLECULAR PSYCHIATRY (2013)
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Pierre Paoletti et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai population
Rachanee Chanasong et al.
NEUROSCIENCE LETTERS (2013)
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis
Silvia Rossi et al.
PLOS ONE (2013)
Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders
Kathryn J. Lester et al.
BIOLOGY OF MOOD & ANXIETY DISORDERS (2013)
A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
Lobna Ibrahim et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder
Pino Alonso et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2012)
N-methyl-D-aspartate receptor 2B subunit (GRIN2B) gene variation is associated with alerting, but not with orienting and conflicting in the Attention Network Test
Stefanie Schulz et al.
NEUROPHARMACOLOGY (2012)
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans
Francesco Mori et al.
JOURNAL OF NEUROPHYSIOLOGY (2011)
Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders
Molly K. Larson et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
Sanjay J. Mathew et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Association analysis of GRIN1 and GRIN2B polymorphisms and Parkinson's disease in a hospital-based case-control study
Shey-Lin Wu et al.
NEUROSCIENCE LETTERS (2010)
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Stephen F. Traynelis et al.
PHARMACOLOGICAL REVIEWS (2010)
Association Between the G1001C Polymorphism in the GRIN1 Gene Promoter and Schizophrenia in the Iranian Population
Hamid Galehdari
JOURNAL OF MOLECULAR NEUROSCIENCE (2009)
Mechanism of differential control of NMDA receptor activity by NR2 subunits
Marc Gielen et al.
NATURE (2009)
Association study of N-methyl-D-aspartate glutamate receptor subunit genes and childhood-onset mood disorders
Kimberley M. Dorval et al.
PSYCHIATRIC GENETICS (2009)
On the hypes and falls in neuroprotection: Targeting the NMDA receptor
Carmen Villmann et al.
NEUROSCIENTIST (2007)
Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample
Alexander Georgi et al.
PSYCHIATRIC GENETICS (2007)
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors
Kevin Erreger et al.
MOLECULAR PHARMACOLOGY (2007)
Role of NMDA receptor subtypes in different forms of NMDA-dependent synaptic plasticity
Rui Li et al.
BMC NEUROSCIENCE (2007)
Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder
K. M. Dorval et al.
GENES BRAIN AND BEHAVIOR (2007)
NMDA receptors and schizophrenia
Lars V. Kristiansen et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia
L. V. Kristiansen et al.
MOLECULAR PSYCHIATRY (2006)
Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia
Sarah M. Clinton et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Generalized and specific neurocognitive deficits in prodromal schizophrenia
T Lencz et al.
BIOLOGICAL PSYCHIATRY (2006)
Significant association between the genetic variations in the 5′ end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia
XZ Zhao et al.
BIOLOGICAL PSYCHIATRY (2006)
An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray
SY Qin et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity
LD Liu et al.
SCIENCE (2004)
Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia
S Begni et al.
BIOLOGICAL PSYCHIATRY (2003)
Epidemiology of women and depression
RC Kessler
JOURNAL OF AFFECTIVE DISORDERS (2003)
Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder
E Mundo et al.
MOLECULAR PSYCHIATRY (2003)
NMDA receptor subunits: diversity, development and disease
S Cull-Candy et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia
T Ohtsuki et al.
MOLECULAR PSYCHIATRY (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
